Hyperprolactinemia, prolactin-related side effects and quality of life in Chinese psychiatric patients
- 1 November 2016
- journal article
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 71, 71-76
Abstract
No abstract availableKeywords
Funding Information
- University of Macau (SRG2014-00019-FHS, MYRG2015-00230-FHS, MYRG2016-00005-FHS)
This publication has 22 references indexed in Scilit:
- Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticosRevista de Psiquiatría y Salud Mental, 2016
- Psychotropic-Induced Hyperprolactinemia: A Clinical ReviewPsychosomatics, 2014
- Frequency of Hyperprolactinemia and Its Associations With Demographic and Clinical Characteristics and Antipsychotic Medications in Psychiatric Inpatients in ChinaPerspectives in Psychiatric Care, 2013
- Safety and tolerability of antipsychotic polypharmacyExpert Opinion on Drug Safety, 2012
- Antipsychotic-Induced HyperprolactinaemiaAustralian & New Zealand Journal of Psychiatry, 2011
- Frequency of Sexual Dysfunction in Patients with a Psychotic Disorder Receiving AntipsychoticsThe Journal of Sexual Medicine, 2010
- Antipsychotics and hyperprolactinaemia: mechanisms, consequences and managementClinical Endocrinology, 2010
- Quality of life and mental health in Chinese cultureCurrent Opinion in Psychiatry, 2010
- A review of the association between antipsychotic use and hyperprolactinaemiaJournal of Psychopharmacology, 2008
- Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum DisordersJournal of Clinical Psychopharmacology, 2007